. Author manuscript; available in PMC: 2014 Dec 1.

Published in final edited form as: J Card Fail. 2013 Oct 29;19(12):10.1016/j.cardfail.2013.10.007. doi: 10.1016/j.cardfail.2013.10.007

Table 3.

HF Medication Adherence based on the MEMS (number of actual dosages/number of prescribed dosages X 100 = % adherence)

Group	Baseline N M ±SD (%)(Min-Max)	4- M N M ±SD (%)(Min-Max)	8-M^* N M ±SD (%)(Min-Max)

Subjects Enrolled [UC, PFE, FPI]	117 [38, 42, 37]	96 [31, 33, 32]	85 [29, 30, 26]

UC	32	25	23
HF Medication	79.5 ± 26.2 (15 – 100)	87.1 ± 14.3 (52 – 100)	87.9 ± 14.6 (48 – 100)

Diuretic	26	22	25
	89.2 ± 15.4 (48 – 100)	89.7 ± 12.7 (62 – 100)	88.0 ± 14.4 (49 – 100)

PFE	35	27	26
HF Medication	91.2 ± 12.5 (43 – 100)	89.2 ± 16.4 (33 – 100)	89.5 ± 14.1 (52 – 100)

Diuretic	34	27	26
	91.9 ± 13.6 (53 – 100)	85.6 ± 17.8 (43 – 100)	83.8 ± 19.9 (33 – 100)

FPI	34	22	20
HF Medication	87.3 ± 19.7 (38 – 100)	85.5 ± 19.6 (29 – 100)	82.9 ± 22.6 (29 – 100)

Diuretic ^*	29	18	16
	83.8 ± 26.1 (10 – 100)	84.9 ± 23.0 (33 – 100)	73.2 ± 30.1 (19 – 100)

No significant overall differences by group or time.

For diuretic doses, there was a significant decline in FPI between BL and 8M (p=.037), and there was a significant difference between usual care and FPI at 8 M (p=.032).